Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0Q8LD | ISIN: BMG210A71016 | Ticker-Symbol: MX6A
Frankfurt
24.01.25
09:15 Uhr
0,498 Euro
-0,012
-2,35 %
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
GRAND PHARMACEUTICAL GROUP LTD Chart 1 Jahr
5-Tage-Chart
GRAND PHARMACEUTICAL GROUP LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,4980,55026.01.
0,5000,54524.01.

Aktuelle News zur GRAND PHARMACEUTICAL GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.01.GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE REGISTRATION CLINICAL STUDY CONDUCTED IN CHINA OF THE GLOBAL INNOVATIVE TEMPERATURE-SENSITIVE EMBOLIC ...2
16.12.24GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: NDA FOR A GLOBAL INNOVATIVE PRODUCT OF THE GROUP TREATED FOR DEMODEX BLEPHARITIS HAS BEEN ACCEPTED BY NMPA-
13.12.24GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE PHASE II CLINICAL STUDY IN CHINA OF THE GROUPS GLOBAL INNOVATIVE PRODUCT STC3141 HAS COMPLETED THE ENROLLMENT ...1
GRAND PHARMACEUTICAL GROUP Aktie jetzt für 0€ handeln
12.12.24GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE GROUPS GLOBAL INNOVATIVE INTRAVASCULAR DUAL-MODE IMAGING SYSTEM NOVASYNC WAS APPROVED BY NMPA FOR COMMERCIALIZATION ...-
11.12.24GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE GROUP OBTAINED THE EXCLUSIVE DEVELOPMENT AND COMMERCIALIZATION RIGHTS OF THE WORLDS FIRST INNOVATIVE ...1
28.11.24GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE PHASE III CLINICAL STUDY CONDUCTED IN CHINA OF THE GLOBAL INNOVATIVE RDC TLX250-CDX HAS COMPLETED THE ...-
15.11.24GRAND PHARMA (00512): CONTINUING CONNECTED TRANSACTION: 2024 DISTRIBUTION AGREEMENTS WITH SIRTEX MEDICA3
04.11.24GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE PHASE III CLINICAL STUDY OF THE GROUPS GLOBAL INNOVATIVE OPHTHALMIC DRUG GPN00833 CONDUCTED IN CHINA ...-
22.10.24GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT: THE FIRST ADJUSTABLE INTRACRANIAL STENT RETRIEVER PRODUCT THAT PRODUCED IN CHINA OF THE GROUP WAS APPROVED ...1
14.10.24GRAND PHARMA (00512): VOLUNTARY ANNOUNCEMENT - THE PHASE III CLINICAL TRIAL APPLICATION IN CHINA OF THE GLOBAL INNOVATIVE RDC DRUG OF THE GROUP ITM-11 ...2
25.09.24GRAND PHARMA (00512): NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT-
25.09.24GRAND PHARMA (00512): INTERIM REPORT 20243
25.09.24GRAND PHARMA (00512): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF INTERIM REPORT1
16.09.24Sirtex Medical Announces Certification of SIR-Spheres Y-90 Resin Microspheres According to Medical Device Regulation (EU) 2017/745 and European Launch of the Innovative SIROS Delivery System413Sirtex brings an innovative liver cancer treatment delivery system to Europe, enhancing options for physicians and their patients. WOBURN, Mass., Sept. 16, 2024 /PRNewswire/ -- Sirtex...
► Artikel lesen
30.08.24GRAND PHARMA (00512): CLARIFICATION ANNOUNCEMENT IN RELATION TO APPOINTMENT OF DIRECTOR 1
27.08.24GRAND PHARMA (00512): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION-
27.08.24GRAND PHARMA (00512): APPOINTMENT OF EXECUTIVE DIRECTOR1
19.08.24GRAND PHARMA (00512): 2024 INTERIM RESULTS ANNOUNCEMENT2
14.08.24GRAND PHARMA (00512): PROFIT ALERT1
08.08.24GRAND PHARMA (00512): DATE OF BOARD MEETING-
Seite:  Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1